Dietary isoflavones linked to increased risk of advanced prostate cancer

Dietary intake of isoflavones was linked with an elevated risk of advanced prostate cancer in a recent International Journal of Cancer study. No statistically significant associations were observed between the intake of isoflavones and non-advanced prostate cancer.

Isoflavones are a type of phytoestrogen, a family of estrogen-like compounds found in plants, and are found in soybeans, kudzu root, and American groundnuts.

During a median follow up of 11.5 years, 2598 cases of prostate (including 287 advanced cases) were identified among 27,004 men in the intervention arm of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Dietary intake was assessed with a food frequency questionnaire.

"Prostate cancer is a major cancer in Western countries and its incidence rate has been remarkably increasing in Asian countries during the last several decades," said senior author Dr. Jianjun Zhang, of the Indiana University Fairbanks School of Public Health. "Our study offers novel evidence that of isoflavones has different effects on advanced and non-advanced prostate cancer. This observation is important for understanding the etiology and prevention of but needs to be confirmed in more epidemiologic studies among populations with diverse dietary habits."


Explore further

Soybean consumption may be beneficial for some women with breast cancer

More information: International Journal of Cancer (2017). DOI: 10.1002/ijc.31095
Journal information: International Journal of Cancer

Provided by Wiley
Citation: Dietary isoflavones linked to increased risk of advanced prostate cancer (2017, November 8) retrieved 13 December 2019 from https://medicalxpress.com/news/2017-11-dietary-isoflavones-linked-advanced-prostate.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments